Variables | Ganciclovir treated (n = 66) | Non-treated (n = 70) | P value |
---|---|---|---|
Sex, male | 47 (71.2) | 40 (57.1) | 0.088 |
Age (years) | 71.5 (62.3–80.0) | 69 (59.8–76.0) | 0.419 |
Pneumonia | 60 (90.9) | 64 (91.4) | 0.915 |
Severity variables | |||
ICU | 29 (43.9) | 17 (24.3) | 0.015 |
Mechanical ventilation | 16 (24.2) | 10 (14.3) | 0.140 |
Quick SOFA | 1 (0.0–2.0) | 1 (1.0–1.0) | 0.650 |
CWI | 1 (1.0–2.0) | 1 (0.0–1.3) | 0.177 |
HD > 30 days after CMV reactivation | 42 (63.6) | 31 (44.3) | 0.024 |
CMV PCR > 5000 copies/ml | 32(48.5) | 16 (22.9) | < 0.002 |
CMV DNAemia duration (days) | 12 (9.0–19.0) | 8.5 (7.0–15.5) | 0.137 |
Progress to CMV pneumonitis | 10 (15.2) | 0 (0.0) | 0.001 |
Endpoint | |||
30-months survival | 14/50 (28) | 21/54 (38.9) | 0.240 |
One-year survival | 25/62 (40.3) | 30/61 (49.2) | 0.323 |
90-days survival | 47/63 (74.6) | 60/69 (87) | 0.070 |
Cardiovascular events | 4 (6.1) | 2 (2.9) | 0.363 |